[144] Vera Therapeutics, Inc. SEC Filing
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Reporting notification to sell 2,900 common shares. The Form 144 filing lists 2,900 shares of common stock proposed for sale through Morgan Stanley Smith Barney LLC with dates 02/20/2026 and 02/23/2026.
The filing describes the shares as restricted stock vesting under a registered plan and identifies the transaction as an issuer‑related sale; cash‑flow treatment and sale timing are not detailed in the excerpt.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 for VERA disclose?
The Form 144 discloses a proposed sale of 2,900 common shares through Morgan Stanley Smith Barney LLC with filing dates 02/20/2026 and 02/23/2026. The shares are described as restricted stock vesting under a registered plan.
Who is the broker handling the sale in the VERA Form 144?
The broker listed is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY. The filing ties the proposed sale of 2,900 shares to that broker in the provided excerpt.